 | | Dolutegravir |  | | Published
November 04, 2012; Updated
December 10, 2018 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-03 | | | Selected Reference | | 4. | Cahn P, Pozniak AL, Mingrone H, et al; SAILING Study Team. Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study. Lancet. 2013 Aug 24;382(9893):700-8. | |
|
|
|
